{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:54:28Z","timestamp":1789152868700,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10787-026-02174-w","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:32:17Z","timestamp":1772847137000},"page":"2593-2605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials (2020\u20132025)"],"prefix":"10.1007","volume":"34","author":[{"given":"Sania","family":"Ikram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhasni","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raees","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"1","key":"2174_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5339\/qmj.2021.5","volume":"2021","author":"D Al-Ali","year":"2021","unstructured":"Al-Ali D et al (2021) Fecal microbiota transplants: a review of emerging clinical data on applications, efficacy, and risks (2015\u20132020). Qatar Med J 2021(1):5","journal-title":"Qatar Med J"},{"issue":"9","key":"2174_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100842","volume":"6","author":"L Bartu","year":"2025","unstructured":"Bartu L, Faith JJ (2025) Searching for the perfect match: MINDFUL trial pairs FMT and fiber for ulcerative colitis. Med 6(9):100842","journal-title":"Med"},{"issue":"7","key":"2174_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph14070637","volume":"14","author":"I Ben Ghezala","year":"2021","unstructured":"Ben Ghezala I et al (2021) Small molecule drugs in inflammatory bowel diseases. Pharmaceuticals 14(7):637","journal-title":"Pharmaceuticals"},{"issue":"9","key":"2174_CR4","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/microorganisms12091755","volume":"12","author":"F Fanizzi","year":"2024","unstructured":"Fanizzi F et al (2024) The role of fecal microbiota transplantation in IBD. Microorganisms 12(9):1755","journal-title":"Microorganisms"},{"issue":"1","key":"2174_CR5","doi-asserted-by":"publisher","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng J et al (2023) Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis. Sci Rep 13(1):14494","journal-title":"Sci Rep"},{"issue":"2","key":"2174_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C et al (2022) Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 7(2):141\u2013151","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2174_CR7","volume-title":"Ulcerative colitis-etiology, diagnosis, diet, special populations, and the role of interventional endoscopy","author":"J Jeruc","year":"2022","unstructured":"Jeruc J (2022) Histomorphological diagnosis of ulcerative colitis and associated conditions. Ulcerative colitis-etiology, diagnosis, diet, special populations, and the role of interventional endoscopy. IntechOpen"},{"issue":"6","key":"2174_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.14309\/ajg.0000000000003196","volume":"120","author":"D Kao","year":"2025","unstructured":"Kao D et al (2025) Preliminary results from a multicenter randomized trial using fecal microbiota transplantation to induce remission in patients with mild-to-moderate Crohn\u2019s disease. Am College Gastroenterol ACG 120(6):1334\u20131344","journal-title":"Am College Gastroenterol ACG"},{"key":"2174_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01097-1","author":"GG Kaplan","year":"2025","unstructured":"Kaplan GG (2025) The global burden of inflammatory bowel disease: from 2025 to 2045. Nat Rev Gastroenterol Hepatol. https:\/\/doi.org\/10.1038\/s41575-025-01097-1","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"2174_CR10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia S et al (2022) Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 71(12):2401\u20132413","journal-title":"Gut"},{"issue":"03","key":"2174_CR11","first-page":"39","volume":"1","author":"MA Khan","year":"2025","unstructured":"Khan MA (2025) The role of biologics in inflammatory disease management. Hyderabad J Sci 1(03):39\u201349","journal-title":"Hyderabad J Sci"},{"issue":"1","key":"2174_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2023.101672","volume":"70","author":"S Khan","year":"2024","unstructured":"Khan S et al (2024) Factors influencing the quality of life in inflammatory bowel disease: a comprehensive review. Dis Mon 70(1):101672","journal-title":"Dis Mon"},{"issue":"17","key":"2174_CR13","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3748\/wjg.v29.i17.2666","volume":"29","author":"P Lahtinen","year":"2023","unstructured":"Lahtinen P et al (2023) Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial. World J Gastroenterol 29(17):2666\u20132678","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2174_CR14","volume":"30","author":"CYS Lim","year":"2021","unstructured":"Lim CYS et al (2021) Colorectal cancer survivorship: a systematic review and thematic synthesis of qualitative research. Eur J Cancer Care 30(4):e13421","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"2174_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JP (2021) Risk\u2010of\u2010bias visualization (robvis): an R package and Shiny web app for visualizing risk\u2010of\u2010bias assessments. Res Synth Methods 12(1):55\u201361","journal-title":"Res Synth Methods"},{"issue":"6","key":"2174_CR16","first-page":"802","volume":"34","author":"L Michailidis","year":"2021","unstructured":"Michailidis L et al (2021) Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies. Ann Gastroenterol 34(6):802","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"2174_CR17","doi-asserted-by":"publisher","first-page":"e2165","DOI":"10.1002\/hsr2.2165","volume":"7","author":"SA Nejadghaderi","year":"2024","unstructured":"Nejadghaderi SA, Balibegloo M, Rezaei N (2024) The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: a perspective on the pros and cons. Health Sci Rep 7(6):e2165","journal-title":"Health Sci Rep"},{"issue":"5","key":"2174_CR18","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/brv.12721","volume":"96","author":"RE O'Dea","year":"2021","unstructured":"O\u2019Dea RE et al (2021) Preferred reporting items for systematic reviews and meta\u2010analyses in ecology and evolutionary biology: a PRISMA extension. Biol Rev 96(5):1695\u20131722","journal-title":"Biol Rev"},{"issue":"5","key":"2174_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3904\/kjim.2022.132","volume":"37","author":"J Park","year":"2022","unstructured":"Park J, Cheon JH (2022) Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-\u03b1. Korean J Intern Med 37(5):895","journal-title":"Korean J Intern Med"},{"key":"2174_CR20","doi-asserted-by":"publisher","first-page":"205031212412574","DOI":"10.1177\/20503121241257486","volume":"12","author":"Z Sahle","year":"2024","unstructured":"Sahle Z et al (2024) Fecal microbiota transplantation and next-generation therapies: a review on targeting dysbiosis in metabolic disorders and beyond. SAGE Open Med 12:20503121241257490","journal-title":"SAGE Open Med"},{"key":"2174_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nepr.2021.103194","volume":"56","author":"M Schiavenato","year":"2021","unstructured":"Schiavenato M, Chu F (2021) PICO: What it is and what it is not. Nurse Educ Pract 56:103194","journal-title":"Nurse Educ Pract"},{"issue":"1","key":"2174_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","volume":"17","author":"A Shahini","year":"2023","unstructured":"Shahini A, Shahini A (2023) Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome. J Cell Commun Signal 17(1):55\u201374","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"2174_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40168-020-0792-5","volume":"8","author":"H Sokol","year":"2020","unstructured":"Sokol H et al (2020) Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: a pilot randomized controlled study. Microbiome 8(1):12","journal-title":"Microbiome"},{"issue":"2","key":"2174_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jgh3.12706","volume":"6","author":"SK Vuyyuru","year":"2022","unstructured":"Vuyyuru SK et al (2022) Immune\u2010mediated inflammatory diseases of the gastrointestinal tract: beyond Crohn\u2019s disease and ulcerative colitis. JGH Open 6(2):100\u2013111","journal-title":"JGH Open"},{"issue":"1","key":"2174_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgh.16795","volume":"40","author":"T Zhang","year":"2025","unstructured":"Zhang T et al (2025) Gut microbiome-targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta-analysis. J Gastroenterol Hepatol 40(1):78\u201388","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02174-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:07:52Z","timestamp":1776316072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02174-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2174"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02174-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. No new participants were enrolled in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. No individual data or identifiable information is included in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable. This study is a meta-analysis of previously published data and does not involve any new human or animal participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}